Unravelling genomic differences in cerebrospinal fluid: patients with lung cancer with combined brain parenchymal and meningeal metastasis versus exclusive meningeal metastasis - Poll - MDSpire

Unravelling genomic differences in cerebrospinal fluid: patients with lung cancer with combined brain parenchymal and meningeal metastasis versus exclusive meningeal metastasis

  • By

  • Liwei Sun

  • Jinduo Li

  • Yuan Lv

  • Lin Li

  • Xiaomin Liu

  • September 30, 2025

  • 0 min

Share

Original Source(s)

Unravelling genomic differences in cerebrospinal fluid: patients with lung cancer with combined brain parenchymal and meningeal metastasis versus exclusive meningeal metastasis

  • by Liwei Sun, Jinduo Li, Yuan Lv, Lin Li, Xiaomin Liu

  • September 30, 2025

Related Content

Case Report: Dramatic response to amivantamab plus chemotherapy in EGFR G719A–mutant lung adenocarcinoma with liver and peritoneal metastases

Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells

An ASCO preview: What to watch for at cancer research’s big meeting